Sign in
NAGE Stock Price, Chart, Stats & News
Niagen Bioscience Inc
Save
277.56M
Market cap
16.60x
Current P/E
13.40x
Forward P/E
NAGE chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 64.28% |
Operating margin | 11.05% |
Pretax margin | 14.06% |
Net margin | 13.43% |
Effective tax rate | 4.45% |
ROA | 16.34% |
ROE | 26.06% |
D/E | 0.04x |
Interest coverage ratio | – |
NAGE valuation
P/E | 16.60x |
P/S | 2.60x |
P/B | 4.33x |
P/CF | 24.66x |
P/FCF | 25.56x |
P/OCF | 24.66x |
PEG | -1.24x |
EV multiple | 23.93x |
About
Niagen Bioscience Inc operates as a biotechnology enterprise with a core focus on promoting healthy aging.
Similar securities
Based on sector and market capitalization
Report issue